SPOTLIGHT -
Dr. Branagan on Novel Induction Therapies With Transplant in Myeloma
Andrew Branagan, MD, discusses novel induction therapies being used with transplant to improve outcomes in patients with multiple myeloma.
Read More
Dr. Branagan on the Role of Transplant in High-Risk Multiple Myeloma
Andrew Branagan, MD, discusses the role of autologous stem cell transplantation in patients with high-risk multiple myeloma.
Dr. Branagan on the Results of the TOURMALINE-MM3 Trial in Multiple Myeloma
Andrew Branagan, MD, discusses the results of the phase 3 TOURMALINE-MM3 trial in multiple myeloma.
Dr. Branagan on Tandem Transplants in Multiple Myeloma
Andrew Branagan, MD, discusses the research tandem transplants in patients with high-risk multiple myeloma.
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
